<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A3562</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 3562 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED FEBRUARY 5, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  SHANIQUE SPEIGHT</p>

<p class=bpuSponsor>District 29 (Essex and Hudson)</p>

<p class=bpuSponsor>Assemblywoman  ROSAURA &quot;ROSY&quot; BAGOLIE</p>

<p class=bpuSponsor>District 27 (Essex and Passaic)</p>

<p class=bpuSponsor>Assemblywoman  VERLINA REYNOLDS-JACKSON</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Requires health insurers to cover self-measured blood
pressure monitoring for subscribers with preeclampsia; requires health care
professionals to provide home blood pressure monitor to pregnant patients
diagnosed with preeclampsia. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning preeclampsia and blood pressure
monitoring and supplementing various parts of statutory law.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    The Legislature finds
and declares:</p>

<p class=MsoNormal style='line-height:150%'>     a.     <span style='color:
black;background:white'>Preeclampsia is a rapidly progressive increase in blood
pressure that occurs after 20 weeks of pregnancy. Although this high blood
pressure usually goes away after birth, it is dangerous for both the mother and
baby and can lead to life-threatening complications. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black;
background:white'>     b.    The condition can keep the baby from getting
proper amounts of blood and oxygen from the mother. Preeclampsia can also cause
the mother to have serious problems with her brain, liver, and kidneys. The
most severe cases of preeclampsia can lead to seizures. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black;
background:white'>     c.     The rate of preeclampsia in the United States has
increased in the last two decades and is a leading cause of maternal and infant
illness and death.  Currently, </span><span style='color:#2B2B2B;background:
white'>preeclampsia affects 5 to 8 percent of pregnant women, or approximately
5,000 to 8,000 individuals in New Jersey annually.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:#2B2B2B;
background:white'>     d.    </span><span style='color:black'>Monitoring blood
pressure is therefore an essential part of prenatal and postpartum care.  </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     Self-measured
blood pressure monitoring in a patients home can be particularly critical in
the case of masked hypertension, where blood pressure levels are elevated at
home despite normal blood pressure in a clinical setting.  In addition, sudden
rises in blood pressure can threaten pregnant women between prenatal appointments
or if they have limited access to healthcare; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     f.     Access
to blood pressure measurement devices or limited knowledge on how to utilize a
device should not be barriers to home-based monitoring. Early detection of high
blood pressure in pregnancy may improve outcomes and<strong> </strong><strong><span
style='font-weight:normal'>prevent</span> t</strong></span><span
style='color:#333333'>he maternal and neonatal morbidities associated with
preeclampsia; and </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:#333333'>     g.    Providing
pregnant patients in New Jersey with home blood pressure measurement monitors
and the training to use such a monitor is a simple, low cost tool to
significantly improve maternal outcomes in the State. </span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    a.  A hospital service
corporation which provides hospital or medical expense benefits under a
contract that is delivered, issued, executed, or renewed in this State or
approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of this act, shall provide
coverage for self-measured blood pressure monitoring for any subscriber who is
diagnosed with preeclampsia, which coverage shall include the provision of a
validated home blood pressure monitor and the reimbursement of provider time
used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor. </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those hospital service corporation contracts in which the hospital
service corporation has reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    a.  A medical service
corporation which provides hospital or medical expense benefits under a
contract that is delivered, issued, executed, or renewed in this State or
approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of this act, shall provide
coverage for self-measured blood pressure monitoring for any subscriber who is
diagnosed with preeclampsia, which coverage shall include the provision of a
validated home blood pressure monitor and the reimbursement of provider time
used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those medical service corporation contracts in which the medical
service corporation has reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    a.  A health service
corporation which provides hospital or medical expense benefits under a
contract that is delivered, issued, executed, or renewed in this State or
approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of this act shall provide
coverage for self-measured blood pressure monitoring for any subscriber who is
diagnosed with preeclampsia, which coverage shall include the provision of a
validated home blood pressure monitor and the reimbursement of provider time
used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those health service corporation contracts in which the health service
corporation has reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    a.  An individual health
insurance policy which provides hospital or medical expense benefits under a
policy that is delivered, issued, executed, or renewed in this State or
approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of this act, shall provide
coverage for self-measured blood pressure monitoring for any subscriber who is
diagnosed with preeclampsia, which coverage shall include the provision of a
validated home blood pressure monitor and the reimbursement of provider time
used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those policies in which the insurer has reserved the right to change
the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    a.  A group health
insurance policy which provides hospital or medical expense benefits under a
policy that is delivered, issued, executed, or renewed in this State or
approved for issuance or renewal in this State by the Commissioner of Banking
and Insurance, on or after the effective date of this act, shall provide
coverage for self-measured blood pressure monitoring for any subscriber who is
diagnosed with preeclampsia, which coverage shall include the provision of a
validated home blood pressure monitor and the reimbursement of provider time
used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those policies in which the insurer has reserved the right to change
the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.    a.  A certificate of
authority to establish and operate a health maintenance organization in this
State shall not be issued or continued on or after the effective date of this
act by the Commissioner of Banking and Insurance unless the health maintenance
organization provides coverage for self-measured blood pressure monitoring for
any subscriber who is diagnosed with preeclampsia, which coverage shall include
the provision of a validated home blood pressure monitor and the reimbursement
of provider time used to educate and train the subscriber on the proper use of
the blood pressure monitor, to transmit blood pressure data from the
subscribers blood pressure monitor, and to interpret blood pressure data from
the subscribers blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     The provisions of this
section shall apply to those contracts for health care services by health
maintenance organizations under which the health maintenance organization has
reserved the right to change the schedule of charges for enrollee coverage.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.    a.  An individual health
benefits plan that is delivered, issued, executed, renewed, or approved for
issuance or renewal in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et
seq.), or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, shall
provide coverage for self-measured blood pressure monitoring for any subscriber
who is diagnosed with preeclampsia, which coverage shall include the provision
of a validated home blood pressure monitor and the reimbursement of provider
time used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be provided
to the same extent as for any other medical condition under the health benefits
plan.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those health benefits plans in which the carrier has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     9.    a.  A small employer
health benefits plan that provides hospital and medical expense benefits and is
delivered, issued, executed, or renewed in this State pursuant to P.L.1992,
c.162 (C.17B:27A-17 et seq.), on or after the effective date of this act, shall
provide coverage for self-measured blood pressure monitoring for any subscriber
who is diagnosed with preeclampsia, which coverage shall include the provision
of a validated home blood pressure monitor and the reimbursement of provider
time used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other condition under the health
benefits plan.</p>

<p class=MsoNormal style='line-height:150%'>     c.     This section shall
apply to those health benefits plans in which the carrier has reserved the
right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     d.    As used in this section,
</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     10.  a.  Notwithstanding any
other provision of law to the contrary, the State Health Benefits Commission
shall ensure that every contract purchased by the commission on or after the
effective date of this act that provides hospital or medical expense benefits shall
provide coverage for self-measured blood pressure monitoring for any subscriber
who is diagnosed with preeclampsia, which coverage shall include the provision
of a validated home blood pressure monitor and the reimbursement of provider
time used to educate and train the subscriber on the proper use of the blood
pressure monitor, to transmit blood pressure data from the subscribers blood
pressure monitor, and to interpret blood pressure data from the subscribers
blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     As used in this
section, </p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     11.  a.  Notwithstanding any
other provision of law to the contrary, the School Employees Health Benefits
Commission shall ensure that every contract purchased by the commission on or
after the effective date of this act that provides hospital or medical expense
benefits shall provide coverage for self-measured blood pressure monitoring for
any subscriber who is diagnosed with preeclampsia, which coverage shall include
the provision of a validated home blood pressure monitor and the reimbursement
of provider time used to educate and train the subscriber on the proper use of
the blood pressure monitor, to transmit blood pressure data from the
subscribers blood pressure monitor, and to interpret blood pressure data from
the subscribers blood pressure monitor.  </p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     As used in this
section, </p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     12.  a.  Notwithstanding any
State law or regulation to the contrary, the Division of Medical Assistance and
Health Services in the Department of Human Services shall, contingent on
maintaining or receiving necessary federal approvals, ensure coverage for
self-measured blood pressure monitoring under the Medicaid program, established
pursuant to P.L.1968, c.413 (C.30:4D-1 et seq.), provided that the eligible
person has been diagnosed with preeclampsia.  Coverage for self-measured blood
pressure monitoring shall include the provision of a validated home blood
pressure monitor and the reimbursement of provider time used to educate and
train the subscriber on the proper use of the blood pressure monitor, to
transmit blood pressure data from the subscribers blood pressure monitor, and
to interpret blood pressure data from the subscribers blood pressure monitor.</p>

<p class=MsoNormal style='line-height:150%'>     b.    This benefit shall be
provided to the same extent as for any other medical condition under the
contract.</p>

<p class=MsoNormal style='line-height:150%'>     c.     As used in this
section, </p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring means the regular measurement of blood pressure by a patient
outside the clinical setting, either at home or elsewhere, requiring the use of
a home blood pressure measurement device by the patient.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>     d.    The Commissioner of
Human Services shall apply for such State plan amendments or waivers as may be
necessary to implement the provisions of this section and to secure federal
financial participation for State expenditures under the federal Medicaid
program.<br clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal style='line-height:150%'>     13.  a.  As used in this
section:</p>

<p class=MsoNormal style='line-height:150%'>     Preeclampsia means a high
blood pressure disorder that can occur during or after pregnancy and may
include, but is by no means limited to, high levels of protein in the patients
urine and other signs of organ damage.</p>

<p class=MsoNormal style='line-height:150%'>     Validated home blood
measurement monitor means a blood pressure measurement device that has been
validated for accuracy and is listed in the United States Blood Pressure
Validated Device Listing.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The Commissioner of
Health shall require every hospital in the State, every birthing center
licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.), every
federally qualified health center in the State, and every physician or health
care practitioner in the State providing care to a pregnant person, to provide,
without cost to the patient,:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   a validated home blood
pressure monitor to a pregnant patient who is diagnosed with preeclampsia;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   a validated home blood
pressure monitor to a pregnant patient who expresses fear or anxiety regarding
the patients blood pressure and who requests a blood pressure monitor; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)   printed educational
material regarding preeclampsia to each pregnant patient at the patients first
pregnancy visit.  The educational material shall be developed and distributed to
providers by the Department of Health and shall include, at a minimum, the
following information:  a definition of preeclampsia; the symptoms and warning
signs of preeclampsia and at what point a patient experiencing those symptoms
or warning signs should contact a medical professional; and a description of
how a patient can advocate for themselves in regard to addressing preeclampsia.</p>

<p class=MsoNormal style='line-height:150%'>     c.     A hospital, a birthing
center, a federally qualified health, or a physician or health care
practitioner that provides a patient with a validated home blood pressure
monitor pursuant to paragraphs (1) and (2) of subsection b. of this section
shall, in accordance with guidelines developed by the commissioner, educate and
train the patient on the proper use of the blood pressure monitor; transmit
blood pressure data from the patients blood pressure monitor; interpret blood
pressure data from the patients blood pressure monitor; and report to the
Department of Health, one year after the effective date of this act and annually
thereafter, de-identifiable data on the number of patients who received blood
pressure monitors under this section and the health outcomes of those patients.</p>

<p class=MsoNormal style='line-height:150%'>     d.    The Department of Health
shall establish a process by which a hospital, a birthing center, a federally
qualified health center, or a physician or health care practitioner that
provides a patient with a validated home blood pressure monitor pursuant to
paragraphs (1) and (2) of subsection b. of this section shall be able to submit
a claim to the department for the reimbursement of the cost of the validated
home blood pressure monitor and any provider time used to educate and train the
patient on the proper use of the blood pressure monitor, to transmit blood
pressure data from the patients blood pressure monitor, and to interpret blood
pressure data from the patients blood pressure monitor, provided that the patient
does not have coverage of such benefits from a third party, such as an
insurance carrier or medical assistance program.   </p>

<p class=MsoNormal style='line-height:150%'>     e.     The Commissioner of
Health shall report to the Governor and to the Legislature,<span
style='color:black'> pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1),</span>
18 months after the effective date of this act, and annually thereafter, on the
health care outcomes of patients provided blood pressure monitors under this
section, which report shall include:  the number of patients who received blood
pressure monitors, disaggregated by those patients who were diagnosed with
preeclampsia and those patients who requested blood pressure monitors; and the
number of patients who received blood pressure monitors and who:  (1) had
documented improvement with blood pressure following the receipt of the
monitor; (2) required hospitalization due to blood pressure issues following
the receipt of the monitor; and (3) experienced maternal mortality attributable
to preeclampsia.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     14.  The Commissioner of
Health, pursuant to the &quot;Administrative Procedure Act,&quot; P.L.1968,
c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effectuate the
purposes of section 13 of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     15.  There is appropriated
from the General Fund to the Department of Health $1,000,000 to issue
reimbursements for claims submitted to the department pursuant to subsection d.
of section 13 of this act.  Any amount of unspent balance from this
appropriation at the end of the current fiscal year shall be appropriated for
the same purpose in the following fiscal year.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     16.  This act shall take
effect on the first day of the fourth month next following the date of
enactment.  Sections 2 through 12 of this act shall apply to all contracts and
policies that are delivered, issued, executed, or renewed or approved for
issuance or renewal in this State on or after the effective date.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='color:black;
letter-spacing:0pt'>     This bill directs the Commissioner of Health to
require every hospital in the State, every birthing center licensed in the
State, every federally qualified health center in the State, and every
physician or health care practitioner in the State providing care to a pregnant
person, to </span>provide, without cost to the patient,:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   a validated home blood
pressure monitor to a pregnant patient who is diagnosed with preeclampsia;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   a validated home blood
pressure monitor to a pregnant patient who expresses fear or anxiety regarding
the patients blood pressure and who requests a blood pressure monitor; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)   printed educational
material regarding preeclampsia to each pregnant patient at the patients first
pregnancy visit.  The educational material shall be developed and distributed
to providers by the Department of Health and shall include, at a minimum, the
following information:  a definition of preeclampsia; the symptoms and warning
signs of preeclampsia and at what point a patient experiencing those symptoms
or warning signs should contact a medical professional; and a description of
how a patient can advocate for themselves in regard to addressing preeclampsia.</p>

<p class=MsoNormal style='line-height:150%'>     The sponsors goal is to
provide pregnant patients in New Jersey, particularly those diagnosed with
preeclampsia, with home blood pressure monitors and the training to use such a
monitor to improve maternal outcomes in the State.  Preeclampsia is a high
blood pressure disorder that can occur during or after pregnancy.  The
condition <span style='background:white'>can keep the baby from getting proper
amounts of blood and oxygen from the mother.  Preeclampsia can also cause the
mother to have serious problems with her brain, liver, and kidneys.</span> 
Monitoring blood pressure is therefore an essential part of prenatal and
postpartum care.  </p>

<p class=MsoNormal style='line-height:150%'>     Self-measured blood pressure
monitoring in a patients home can be particularly critical in the case of
masked <span style='color:black'>hypertension, where blood pressure levels are
elevated at home despite normal blood pressure in a clinical setting.  In
addition, sudden rises in blood pressure can threaten pregnant women between
prenatal appointments or if they have limited access to healthcare.  This bill
seeks to eliminate barriers to home-based monitoring, such as access to </span>blood
pressure measurement devices or limited knowledge on how to utilize a device.  In
doing so, this bill provides for the early detection of life-threatening high
blood pressure in pregnancy, thereby<b> </b><strong><span style='font-weight:
normal'>preventing</span> t</strong>he maternal and neonatal morbidities
associated with preeclampsia. </p>

<p class=MsoNormal style='line-height:150%'>     In addition, the bill directs
that a hospital, a birthing center, a federally qualified health center, or a physician
or health care practitioner that provides a patient a validated home blood
pressure monitor pursuant to the bill is required, in accordance with
guidelines developed by the commissioner, to educate and train the patient on
the proper use of the blood pressure monitor; to transmit blood pressure data
from the patients blood pressure monitor; to interpret blood pressure data
from the patients blood pressure monitor; and to report to the Department of
Health, one year after the effective date of this act and annually thereafter,
de-identifiable data on the number of patients who received blood pressure
monitors under this section and the health outcomes of those patients.</p>

<p class=MsoNormal style='line-height:150%;text-autospace:none'>     The bill
also directs the Department of Health to establish a process by which a hospital,
a birthing center, a federally qualified health center, or a physician or
health care practitioner that provides a patient with a validated home blood
pressure monitor under the bill is able to submit a claim to the department for
the reimbursement of the cost of the validated home blood pressure monitor and
any provider time used to educate and train the patient on the proper use of
the blood pressure monitor, to transmit blood pressure data from the patients
blood pressure monitor, and to interpret blood pressure data from the patients
blood pressure monitor, provided that the patient does not have coverage of
such benefits from a third party, such as an insurance carrier or medical
assistance program.  The bill appropriations $1 million to the department to
issue these reimbursements and requires that any unspent balance at the end of
the current fiscal year be appropriated for the same purpose in the next fiscal
year. </p>

<p class=MsoNormal style='line-height:150%;text-autospace:none'>     Finally,
under the bill, the Commissioner of Health is mandated to report to the
Governor and to the Legislature, 18 months after the effective date of the bill,
and annually thereafter, on the health care outcomes of patients provided blood
pressure monitors under the bill, which report is to include:  the number of
patients who received blood pressure monitors, disaggregated by those patients
who were diagnosed with preeclampsia and those patients who requested blood
pressure monitors; and the number of patients who received blood pressure
monitors who: had documented improvement with blood pressure following the
receipt of the monitor, required hospitalization due to blood pressure issues
following the receipt of the monitor, and experienced maternal mortality
related to preeclampsia.<span style='font-family:"Arial",sans-serif;color:black;
letter-spacing:0pt'>       </span></p>

<p class=MsoNormal style='line-height:150%;text-autospace:none'><span
style='font-family:"Arial",sans-serif;color:black;letter-spacing:0pt'>     </span><span
style='color:black;letter-spacing:0pt'>The bill also requires health insurers
to </span>provide coverage for self-measured blood pressure monitoring for any
subscriber who is diagnosed with preeclampsia, which coverage is to include the
provision of a validated home blood pressure monitor and the reimbursement of
provider time used to educate and train the subscriber on the proper use of the
blood pressure monitor, to transmit blood pressure data from the subscribers
blood pressure monitor, and to interpret blood pressure data from the
subscribers blood pressure monitor.  <span style='color:black;letter-spacing:
0pt'>Specifically, this provision of the bill affects health, hospital, and
medical service corporations; individual and group health insurance policies; health
maintenance organizations; individual health benefits plans; small employer
health benefits plans; the State Health Benefits Program; the School Employees
Health Benefits Program; and the State Medicaid Program.</span></p>

</div>

</body>

</html>
